Community pharmacies incentivised to refer frequent users of reliever inhalers to general practice The new referral incentive will be part of the Pharmacy Quality Scheme for 2022/2023.…
NHS Scotland announces plan to switch patients to greener inhalers A strategy document, published by NHS Scotland, says that improvements in the way asthma and chronic obstructive pulmonary disease are managed could help reduce metered dose inhaler use.…
Best practice principles for inhaler prescribing How to select appropriate inhaler devices that balance the need to personalise treatment and optimise disease control while reducing the environmental impact of prescribing.…
More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
Post-Paxlovid viral rebound – what do we know and should we be worried? With reports of sudden viral rebound in patients days after completing the treatment regimen for the antiviral Paxlovid, we take a look at what this may mean for our protection against COVID-19.…
Monoclonal antibody 75% effective in infants against respiratory viral infection Nirsevimab could become the first immunisation against respiratory syncytial virus for all infants.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
Pharmacist antibiotic use doubles after sore throat testing requirement is removed Data from the Welsh community pharmacy Sore Throat Test and Treat (STTT) service show that antibiotic prescribing increased from 27% to 63% during the COVID-19 pandemic.…
NICE removes budesonide from recommended COVID-19 treatments In updated guidance, the National Institute for Health and Care Excellence said there was “no statistically significant difference” between patients treated with inhaled budesonide for COVID-19 and those who received usual care.…
